Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by bayoubuckson Jun 02, 2014 12:51pm

292 Views

Post# 22621393

Laser revenue

I just finished listening to the InvestorIntel interview with Roger and am puzzled about his revenue projections. He said with the introduction of the TLC-2000 They expected 2014 revenue to be $6 million. How are they going to do that if current revenue is about $1.5 mil and they're not coming out with the TLC-2000 until Q4?
3/31 revenue was $362,000. So, extrapolating that for Q's 2&3, would put revenue at a little over a million. That would mean $5 mil in Q4? Hmmmmmmmmm. Anyone else pick up on this or can enlighten me? Don't get me wrong, I love this company and am well into 5 figures in shs, but the numbers just don't add up.

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season